VIADERMA CLEAR ACNE TREATMENT- salicylic acid ointment

Viaderma Clear Acne Treatment by

Drug Labeling and Warnings

Viaderma Clear Acne Treatment by is a Otc medication manufactured, distributed, or labeled by ViaDerma Distribution, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DRUG FACTS

Active ingredients

Salicylic Acid 2%

Purposes

Acne Treatment

Uses

• For the treatment of acne.
• Clears up most acne blemishes, acne pimples, blackheads and allows skin to heal.
• Penetrates pores to eliminate most of acne conditions.
• Helps prevent new acne blemishes, pimples and blackheads from forming.

Warnings

For external use only.

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Clean the skin thoroughly before applying this product
• Cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• If bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

• Store between 68-77°F (20-25°C)
• Avoid extreme temperatures (freezing or heating)

Other ingredients

Acetic acid, ascorbic acid, butylated hydroxyanisole, butylated hydroxytoluene, cholecalciferol, dimethyl sulfoxide, dipropylene glycol, gluconolactone, glycerin, histidine, hydroxyethyl-cellulose, magnesium stearate, sodium hydroxide, sorbic acid, water.

Questions?

Report any serious adverse events
to: Viaderma Distribution Inc. or call:
1-800-585-8685.

Package Labeling:

INGREDIENTS AND APPEARANCE

VIADERMA CLEAR ACNE TREATMENT 
salicylic acid ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71262-016
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
ACETIC ACID (UNII: Q40Q9N063P)
ASCORBIC ACID (UNII: PQ6CK8PD0R)
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
CHOLECALCIFEROL (UNII: 1C6V77QF41)
DIMETHYL SULFOXIDE (UNII: YOW8V9698H)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
GLUCONOLACTONE (UNII: WQ29KQ9POT)
GLYCERIN (UNII: PDC6A3C0OX)
HISTIDINE (UNII: 4QD397987E)
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)
MAGNESIUM STEARATE (UNII: 70097M6I30)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SORBIC ACID (UNII: X045WJ989B)
WATER (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71262-016-15	1 in 1 CARTON	10/17/2025
1		15 g in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	10/17/2025

Labeler - ViaDerma Distribution, Inc. (081113521)

Registrant - ViaDerma Distribution, Inc. (081113521)